{"id":"W2236030964","doi":"10.1176/appi.ajp.2015.15050648","title":"Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial","year":2016,"lang":"en","type":"article","venue":"American Journal of Psychiatry","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":97,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Aging; Canadian Institutes of Health Research; Avid Radiopharmaceuticals; Genentech; National Institutes of Health; Lundbeck Canada; National Football League Players Association; Grifols; Servier; Eisai; Astellas Pharma; Pfizer; Biogen; Centre for Addiction and Mental Health Foundation; Fondation Brain Canada; Centre for Addiction and Mental Health; University of Pennsylvania; AstraZeneca; International Parkinson and Movement Disorder Society; GlaxoSmithKline; CHDI Foundation; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Michael J. Fox Foundation for Parkinson's Research; Teva Pharmaceutical Industries; H. Lundbeck A/S; U.S. Department of Veterans Affairs","keywords":"Citalopram; Placebo; Randomized controlled trial; Medicine; Internal medicine; Alzheimer's disease; Psychology; Psychiatry; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024228,0.0002117295,0.0008512614,0.0001576909,0.0001081246,0.00001580878,0.0002714749,0.00005487503,0.00004861629],"category_scores_gemma":[0.001641689,0.00007219918,0.0004014727,0.0002532256,0.0005368826,0.00005805601,0.0000136402,0.000119968,0.00000738589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004948595,"about_ca_system_score_gemma":0.0009673302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001915957,"about_ca_topic_score_gemma":0.00002837805,"domain_scores_codex":[0.9955918,0.002229883,0.001204511,0.0002886657,0.0004110587,0.0002740422],"domain_scores_gemma":[0.991152,0.005574197,0.001766714,0.0004801827,0.0005887703,0.0004381033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7816826,0.0008970194,0.01338401,0.000002277252,0.0006541178,0.00002795256,0.0003143813,0.000003836572,7.369537e-7,0.000014267,0.0004854953,0.2025333],"study_design_scores_gemma":[0.7633204,0.08968405,0.1399754,0.001311388,0.0009318487,0.00009859697,0.001546113,0.000002343433,0.000002764436,0.0003513322,0.002485794,0.0002900116],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801924,0.0002594647,0.003571362,0.01245734,0.001898915,0.001520917,0.0000784279,0.000008926169,0.0000122431],"genre_scores_gemma":[0.991381,0.00004580632,0.007271663,0.0006393428,0.0004941298,0.00008897598,0.000002233123,0.00003162887,0.00004520577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2022433,"threshold_uncertainty_score":0.2944197,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05810174455522275,"score_gpt":0.4370109048808895,"score_spread":0.3789091603256667,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}